Table 1.
Patients' characteristics
n (%) | ||
---|---|---|
Sex | male | 26 (74.3) |
female | 9 (25.7) | |
total | 35 (100) | |
MSKCC risk | favourable | 2 (5.7) |
intermediate | 21 (60.0) | |
poor | 4 (11.4) | |
unknown | 8 (22.9) | |
ECOG status | 0 | 21 (60) |
1 | 9 (25.7) | |
> 1 | 1 (2.9) | |
unknown | 4 (11.4) | |
Histology | clear cell | 29 (82.7) |
papillary | 4 (11.4) | |
other | 2 (5.9) | |
Previous immunotherapy | 14 (40) |
Abbreviations:
MSKCC - Memorial Sloan-Kettering Cancer Center;
ECOG - Eastern Cooperative Oncology Group;
rTKI - receptor tyrosine kinase inhibitor.